A folded and functional protein domain in an amyloid-like fibril

Protein Science

Volumn 17, Issue 6, 2008, Pages 1044-1054

  Sackewitz, Mirko ^a   Von Einem, Sabrina ^a   Hause, Gerd ^a   Wunderlich, Michael ^b   Schmid, Franz Xaver ^c   Schwarz, Elisabeth ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

CspB; Fibril formation; PABPN1; Polyalanine; Protein folding

Indexed keywords

ALANINE; AMYLOID; BACTERIAL PROTEIN; COLD SHOCK PROTEIN; NUCLEAR PROTEIN; POLYPEPTIDE; PROTEIN CSPB; PROTEIN PAPBN1;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BACILLUS SUBTILIS; CARBOXY TERMINAL SEQUENCE; FIBER; MUTATION; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE;

AMYLOID; BASE SEQUENCE; CIRCULAR DICHROISM; DNA PRIMERS; MICROSCOPY, ELECTRON; PROTEIN FOLDING; SPECTROPHOTOMETRY, ULTRAVIOLET; THERMODYNAMICS;

BACILLUS SUBTILIS;

EID: 44349141843     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.073276308     Document Type: Article

References (60)

1. Abu-Baker, A. and Rouleau, G.A. 2007. Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim Biophys Acta 1772: 173-185.
2. Abu-Baker, A., Messaed, C., Laganiere, J., Gaspar, C., Brais, B., and Rouleau, G.A. 2003. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 12: 2609-2623.
3. Albrecht, A. and Mundlos, S. 2005. The other trinucleotide repeat: Polyalanine expansion disorders. Curr. Opin. Genet. Dev. 15: 285-293.
4. Amiel, J., Trochet, D., Clement-Ziza, M., Munnich, A., and Lyonnet, S. 2004. Polyalanine expansions in human. Hum. Mol. Genet. 13: (Review issue 2) R235-R243. doi: 10.1093/hmg/ddh251.
5. Andrew, S.E., Goldberg, Y.P., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M.A., et al. 1993. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4: 398-403.
6. Bai, M., Zhou, J.M., and Perrett, S. 2004. The yeast prion protein Ure2 shows glutathione peroxidase activity in both native and fibrillar forms. J. Biol. Chem. 279: 50025-50030.
7. Bao, Y.P., Cook, L.J., O'Donovan, D., Uyama, E., and Rubinsztein, D.C. 2002. Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy. J. Biol. Chem. 277: 12263-12269.
8. Bao, Y.P., Sarkar, S., Uyama, E., and Rubinsztein, D.C. 2004. Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy. J. Med. Genet. 41: 47-51.
9. Baxa, U., Speransky, V., Steven, A.C., and Wickner, R.B. 2002. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc. Natl. Acad. Sci. 99: 5253-5260.
10. Baxa, U., Taylor, K.L., Wall, J.S., Simon, M.N., Cheng, N., Wickner, R.B., and Steven, A.C. 2003. Architecture of Ure2p prion filaments: The N-terminal domains form a central core fiber. J. Biol. Chem. 278: 43717-43727.
11. Borrell-Pages, M., Zala, D., Humbert, S., and Saudou, F. 2006. Huntington's disease: From huntingtin function and dysfunction to therapeutic strategies. Cell. Mol. Life Sci. 63: 2642-2660.
12. Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafreniere, R.G., Rommens, J.M., Uyama, E., Nohira, O., et al. 1998. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18: 164-167.
13. Brinkmann, U., Mattes, R.E., and Buckel, P. 1989. High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene 85: 109-114.
14. Calado, A., Tome, F.M., Brais, B., Rouleau, G.A., Kühn, U., Wahle, E., and Carmo-Fonseca, M. 2000. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum. Mol. Genet. 9: 2321-2328.
15. Chartier, A., Benoit, B., and Simonelig, M. 2006. A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. EMBO J. 25: 2253-2262.
16. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., and Dobson, C.M. 1999a. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. 96: 3590-3594.
17. Chiti, F., Taddei, N., White, P.M., Bucciantini, M., Magherini, F., Stefani, M., and Dobson, C.M. 1999b. Mutational analysis of acylphosphatase suggests the importance of topology and contact order in protein folding. Nat. Struct. Biol. 6: 1005-1009.
18. Davies, J.E., Wang, L., Garcia-Oroz, L., Cook, L.J., Vacher, C., O'Donovan, D.G., and Rubinsztein, D.C. 2005. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat. Med. 11: 672-677.
19. Davies, J.E., Sarkar, S., and Rubinsztein, D.C. 2006. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 15: 23-31.
20. Eftink, M.R. 1997. Fluorescence methods for studying equilibrium macromolecule-ligand interactions. Methods Enzymol. 278: 221-257.
21. Everett, C.M. and Wood, N.W. 2004. Trinucleotide repeats and neurodegenerative disease. Brain 127: 2385-2405.
22. Fan, X., Dion, P., Laganiere, J., Brais, B., and Rouleau, G.A. 2001. Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death. Hum. Mol. Genet. 10: 2341-2351.
23. Gill, S.C. and von Hippel, P.H. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182: 319-326.
24. Graumann, P. and Marahiel, M.A. 1994. The major cold shock protein of Bacillus subtilis CspB binds with high affinity to the ATTGG- and CCAAT sequences in single stranded oligonucleotides. FEBS Lett. 338: 157-160.
25. Hill, D.T., Payne, V.W.E., Rogers, J.W., Kown, S.R., Tomé, F.M.S., Chateau, D., Helbling-Leclerc, A., and Fardeau, M. 1997. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul. Disord. (Suppl 1) 7: S63-S69. doi: 10.1016/S0960-8966(97)00085-0.
26. Krzewska, J., Tanaka, M., Burston, S.G., and Melki, R. 2007. Biochemical and functional analysis of the assembly of full-length Sup35p and its prion-forming domain. J. Biol. Chem. 282: 1679-1686.
27. Kühn, U. and Wahle, E. 2004. Structure and function of poly(A) binding proteins. Biochim. Biophys. Acta 1678: 67-84.
28. Kühn, U., Nemeth, A., Meyer, S., and Wahle, E. 2003. The RNA binding domains of the nuclear poly(A)-binding protein. J. Biol. Chem. 278: 16916-16925.
29. Lazo, N.D., Maji, S.K., Fradinger, E.A., Bitan, G., and Teplow, D.B. 2005. The amyloid β-protein. In Amyloid proteins; The β-sheet conformation and disease (ed. J. Sipe), pp. 385-491. Wiley-VCH Verlag GmbH, Germany.
30. Lodderstedt, G., Hess, S., Hause, G., Scheuermann, T., Scheibel, T., and Schwarz, E. 2007. Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1. FEBS J. 274: 346-355.
31. Lodderstedt, G., Sachs, R., Faust, J., Bordusa, F., Kühn, U., Golbik, R., Kerth, A., Wahle, E., Balbach, J., and Schwarz, E. 2008. Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension. Biochemistry 47: 2181-2189.
32. Lohman, T.M. and Bujalowski, W. 1991. Thermodynamic methods for modelindependent determination of equilibrium binding isotherms for protein-DNA interactions: Spectroscopic approaches to monitor binding. Methods Enzymol. 208: 258-290.
33. Lopez, M.M. and Makhatadze, G.I. 2000. Major cold shock proteins, CspA from Escherichia coli and CspB from Bacillus subtilis, interact differently with single-stranded DNA templates. Biochim. Biophys. Acta 1479: 196-202.
34. Lopez, M.M., Yutani, K., and Makhatadze, G.I. 1999. Interactions of the major cold shock protein of Bacillus subtilis CspB with single-stranded DNA templates of different base composition. J. Biol. Chem. 274: 33601-33608.
35. Lopez, M.M., Yutani, K., and Makhatadze, G.I. 2001. Interactions of the cold shock protein CspB from Bacillus subtilis with single-stranded DNA. Importance of the T base content and position within the template. J. Biol. Chem. 276: 15511-15518.
36. Max, K.E., Zeeb, M., Bienert, R., Balbach, J., and Heinemann, U. 2006. T-rich DNA single strands bind to a preformed site on the bacterial cold shock protein Bs-CspB. J. Mol. Biol. 360: 702-714.
37. Miller, J.S., Kennedy, R.J., and Kemp, D.S. 2001. Short, solubilized polyalanines are conformational chameleons: Exceptionally helical if N- and C-capped with helix stabilizers, weakly to moderately helical if capped with rigid spacers. Biochemistry 40: 305-309.
38. Miller, J.S., Kennedy, R.J., and Kemp, D.S. 2002. Solubilized, spaced polyalanines: A context-free system for determining amino acid α-helix propensities. J. Am. Chem. Soc. 124: 945-962.
39. Pace, C.N. 1986. Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol. 131: 266-280.
40. Pajot, P. 1976. Fluroescence of proteins in 6-M guanidine hydrochloride. A method for the quantitative determination of tryptophan. Eur. J. Biochem. 63: 263-269.
41. Pedersen, J.S., Dikov, D., Flink, J.L., Hjuler, H.A., Christiansen, G., and Otzen, D.E. 2006. The changing face of glucagon fibrillation: Structural polymorphism and conformational imprinting. J. Mol. Biol. 355: 501-523.
42. Petkova, A.T., Leapman, R.D., Guo, Z., Yau, W.M., Mattson, M.P., and Tycko, R. 2005. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307: 262-265.
43. Sambashivan, S., Liu, Y., Sawaya, M.R., Gingery, M., and Eisenberg, D. 2005. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437: 266-269.
44. Santoro, M.M. and Bolen, D.W. 1988. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants. Biochemistry 27: 8063-8068.
45. Scheibel, T. and Buchner, J. 2006. Protein aggregation as a cause for disease. Handb. Exp. Pharmacol. 172: 199-219.
46. Scheuermann, T., Schulz, B., Blume, A., Wahle, E., Rudolph, R., and Schwarz, E. 2003. Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation. Protein Sci. 12: 2685-2692.
47. Schindelin, H., Marahiel, M.A., and Heinemann, U. 1993. Universal nucleic acid-binding domain revealed by crystal structure of the B. subtilis major cold-shock protein. Nature 364: 164-168.
48. Schindler, T., Herrler, M., Marahiel, M.A., and Schmid, F.X. 1995. Extremely rapid protein folding in the absence of intermediates. Nat. Struct. Biol. 2: 663-673.
49. Schnuchel, A., Wiltscheck, R., Czisch, M., Herrler, M., Willimsky, G., Graumann, P., Marahiel, M.A., and Holak, T.A. 1993. Structure in solution of the major cold-shock protein from Bacillus subtilis. Nature 364: 169-171.
50. Scholtz, J.M. and Baldwin, R.L. 1992. The mechanism of a-helix formation by peptides. Annu. Rev. Biophys. Biomol. Struct. 21: 95-118.
51. Selkoe, D.J. 2003. Folding proteins in fatal ways. Nature 426: 900-904.
52. Soto, C., Estrada, L., and Castilla, J. 2006. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 31: 150-155.
53. Tanaka, M., Chien, P., Naber, N., Cooke, R., and Weissman, J.S. 2004. Conformational variations in an infectious protein determine prion strain differences. Nature 428: 323-328.
54. Tomé, F.M., Chateau, D., Helbling-Leclerc, A., and Fardeau, M. 1997. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul. Disord. 7: S63-S69.
55. Wahle, E. 1991. A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation. Cell 66: 759-768.
56. Wahle, E. and Ruegsegger, U. 1999. 39-End processing of pre-mRNA in eukaryotes. FEMS Microbiol. Rev. 23: 277-295.
57. Wallace, R.B. and Miyada, C.G. 1987. Oligonucleotide probes for the screening of recombinant DNA libraries. Methods Enzymol. 152: 432-442.
58. Wang, Q., Mosser, D.D., and Bag, J. 2005. Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells. Hum. Mol. Genet. 14: 3673-3684.
59. Zeeb, M. and Balbach, J. 2003. Single-stranded DNA binding of the cold-shock protein CspB from Bacillus subtilis: NMR mapping and mutational characterization. Protein Sci. 12: 112-123.
60. Zeeb, M., Max, K.E., Weininger, U., Low, C., Sticht, H., and Balbach, J. 2006. Recognition of T-rich single-stranded DNA by the cold shock protein Bs-CspB in solution. Nucleic Acids Res. 34: 4561-4571.